glp-1 afib Association of glucagon-like peptide-1 receptor agonists with atrial fibrillation, cardiac arrest, and ventricular fibrillation: Casual evidence from a drug target Mendelian randomization | Diabetology & Metabolic Syndrome GLP-1 Atrial Fibrillation: What New

Conflict of interest statement The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

Renal, cardiovascular, and safety outcomes of canagliflozin by baseline kidney function: a secondary analysis of the CREDENCE Randomized Trial

10.1021/JF0735073 198 SinghN.ChaputL.VilloutreixB

Common side effects include nausea, vomiting, and diarrhea, which are typically transient

Semaglutide, tirzepatide, liraglutide: You might have heard of these type 2 diabetes medications known as GLP-1 drugs

Patients avoid scheduling appointments weeks in advance, sitting in waiting rooms, or coordinating multiple healthcare providers